Our study showed that ectopic overexpression of GHITM could enhance the sensitivity of renal cancer cells to sunitinib and the antitumor effects of PD‐1 blockade, which was consistent with previous bioinformatics analysis. This evidence concerns the gene GHITM and renal carcinoma.